Franklin Resources’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-237,684
Closed -$1.72M 2419
2022
Q1
$1.72M Sell
237,684
-232,099
-49% -$1.98M ﹤0.01% 1458
2021
Q4
$6.38M Buy
469,783
+3
+0% +$47 ﹤0.01% 1167
2021
Q3
$9.85M Buy
469,780
+253,872
+118% +$5.45M ﹤0.01% 1063
2021
Q2
$5.17M Buy
215,908
+15,900
+8% +$403K ﹤0.01% 1129
2021
Q1
$5.85M Hold
200,008
﹤0.01% 1074
2020
Q4
$5.97M Buy
+200,008
New +$6.28M ﹤0.01% 1059

Other funds holding KRON

Franklin Resources's KRON Position: Q2 2022 in Review

Franklin Resources sold out of Kronos Bio (KRON) in Q2 2022, closing a stake of 237,684 shares — an estimated $1.72M sold.

Franklin Resources first reported a position in KRON in Q4 2020 and held it in 6 quarters. The position peaked at $9.85M in Q3 2021. 93 funds tracked by Wall St. Rank hold KRON as of Q2 2022.

  • Franklin Resources reported no remaining Kronos Bio position as of Q2 2022 after selling out during the quarter.
  • Franklin Resources sold 237,684 Kronos Bio shares in Q2 2022, an estimated $1.72M.
  • Franklin Resources first reported a position in Kronos Bio in Q4 2020 and held it in 6 quarters.
  • Franklin Resources's Kronos Bio position peaked at $9.85M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2022.

Based on Franklin Resources's 13F filing for Q2 2022, filed 11 Aug 2022.